Boston Trust Walden Corp lessened its holdings in Marsh & McLennan Companies, Inc. (NYSE:MMC - Free Report) by 2.3% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 237,831 shares of the financial services provider's stock after selling 5,566 shares during the quarter. Boston Trust Walden Corp's holdings in Marsh & McLennan Companies were worth $58,038,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also bought and sold shares of MMC. Norges Bank bought a new position in Marsh & McLennan Companies during the 4th quarter worth approximately $1,236,186,000. Stifel Financial Corp boosted its stake in Marsh & McLennan Companies by 551.0% during the 4th quarter. Stifel Financial Corp now owns 2,224,932 shares of the financial services provider's stock worth $472,599,000 after acquiring an additional 1,883,146 shares during the last quarter. Amundi boosted its stake in Marsh & McLennan Companies by 81.1% during the 4th quarter. Amundi now owns 4,072,976 shares of the financial services provider's stock worth $860,824,000 after acquiring an additional 1,823,807 shares during the last quarter. GAMMA Investing LLC boosted its stake in Marsh & McLennan Companies by 32,120.9% during the 1st quarter. GAMMA Investing LLC now owns 1,515,670 shares of the financial services provider's stock worth $369,869,000 after acquiring an additional 1,510,966 shares during the last quarter. Finally, Raymond James Financial Inc. bought a new position in Marsh & McLennan Companies during the 4th quarter worth approximately $207,278,000. Institutional investors own 87.99% of the company's stock.
Insider Buying and Selling
In other Marsh & McLennan Companies news, CEO Dean Michael Klisura sold 9,569 shares of the company's stock in a transaction on Monday, March 31st. The shares were sold at an average price of $245.00, for a total value of $2,344,405.00. Following the transaction, the chief executive officer now directly owns 20,935 shares in the company, valued at $5,129,075. The trade was a 31.37% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, SVP Paul Beswick sold 2,237 shares of the company's stock in a transaction on Thursday, April 3rd. The shares were sold at an average price of $246.00, for a total transaction of $550,302.00. Following the completion of the transaction, the senior vice president now owns 13,522 shares in the company, valued at approximately $3,326,412. This represents a 14.20% decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.35% of the stock is owned by corporate insiders.
Wall Street Analyst Weigh In
Several research firms recently weighed in on MMC. Keefe, Bruyette & Woods reduced their price objective on shares of Marsh & McLennan Companies from $220.00 to $215.00 and set an "underperform" rating on the stock in a research note on Monday, April 21st. Jefferies Financial Group lifted their price target on shares of Marsh & McLennan Companies from $237.00 to $244.00 and gave the company a "hold" rating in a research note on Friday, April 11th. Redburn Atlantic initiated coverage on shares of Marsh & McLennan Companies in a research note on Tuesday, March 25th. They issued a "buy" rating and a $281.00 price target on the stock. Wells Fargo & Company lifted their price target on shares of Marsh & McLennan Companies from $223.00 to $232.00 and gave the company an "equal weight" rating in a research note on Thursday, April 10th. Finally, Barclays lifted their price target on shares of Marsh & McLennan Companies from $246.00 to $249.00 and gave the company an "equal weight" rating in a research note on Friday, April 11th. Two analysts have rated the stock with a sell rating, seven have given a hold rating and five have given a buy rating to the stock. According to MarketBeat, the company presently has an average rating of "Hold" and an average price target of $241.93.
Check Out Our Latest Stock Report on Marsh & McLennan Companies
Marsh & McLennan Companies Price Performance
Shares of MMC opened at $214.22 on Thursday. The company has a market cap of $105.55 billion, a price-to-earnings ratio of 26.25, a PEG ratio of 2.65 and a beta of 0.83. Marsh & McLennan Companies, Inc. has a 1-year low of $207.21 and a 1-year high of $248.00. The company's fifty day simple moving average is $225.76 and its 200 day simple moving average is $225.03. The company has a current ratio of 1.14, a quick ratio of 1.14 and a debt-to-equity ratio of 1.32.
Marsh & McLennan Companies (NYSE:MMC - Get Free Report) last issued its earnings results on Thursday, April 17th. The financial services provider reported $3.06 earnings per share for the quarter, topping analysts' consensus estimates of $3.02 by $0.04. The business had revenue of $6.70 billion for the quarter, compared to the consensus estimate of $7.08 billion. Marsh & McLennan Companies had a net margin of 16.13% and a return on equity of 32.19%. During the same period in the previous year, the company earned $2.89 earnings per share. On average, research analysts forecast that Marsh & McLennan Companies, Inc. will post 9.61 earnings per share for the current fiscal year.
Marsh & McLennan Companies Profile
(
Free Report)
Marsh & McLennan Cos., Inc is a professional services firm, which engages in offering clients advice and solutions in risk, strategy, and people. It operates through the Risk and Insurance Services, and Consulting segments. The Risk and Insurance Services segment is involved in risk management activities, as well as insurance and reinsurance broking and services.
Read More
Want to see what other hedge funds are holding MMC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Marsh & McLennan Companies, Inc. (NYSE:MMC - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Marsh & McLennan Companies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Marsh & McLennan Companies wasn't on the list.
While Marsh & McLennan Companies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
